# Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix

> **NCT01580410** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 136 (actual)

## Conditions studied

- Carcinoma of the Appendix
- Primary Peritoneal Cavity Cancer

## Interventions

- **DRUG:** mitomycin C
- **DRUG:** oxaliplatin
- **PROCEDURE:** therapeutic conventional surgery
- **OTHER:** quality-of-life assessment
- **DRUG:** hyperthermic intraperitoneal chemotherapy

## Key facts

- **NCT ID:** NCT01580410
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2015-10
- **Final completion:** 2016-11
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2018-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580410, "Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01580410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*